136 related articles for article (PubMed ID: 1735736)
21. [Augmentation of therapeutic effect of adoptive immunotherapy through a synergy between transferred killer cells and host's fresh lymphocytes].
Kan N; Yamasaki S; Harada T; Satoh K; Ichinose Y; Moriguchi Y; Kodama H; Ohgaki K
Hum Cell; 1992 Sep; 5(3):236-42. PubMed ID: 1467322
[TBL] [Abstract][Full Text] [Related]
22. Locoregional immuno(bio)therapy for liver metastases.
Sato T
Semin Oncol; 2002 Apr; 29(2):160-7. PubMed ID: 11951214
[TBL] [Abstract][Full Text] [Related]
23. Splenectomy abolishes antitumor effect of immunotherapy with streptococcal preparation, OK-432, on mouse liver tumors.
Imai S; Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tobe T
Anticancer Res; 1991; 11(3):1269-74. PubMed ID: 1888159
[TBL] [Abstract][Full Text] [Related]
24. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer.
Li L; Wang W; Pan H; Ma G; Shi X; Xie H; Liu X; Ding Q; Zhou W; Wang S
J Transl Med; 2017 Jan; 15(1):23. PubMed ID: 28137271
[TBL] [Abstract][Full Text] [Related]
25. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages.
Takeda T; Kobayashi T; Monden T; Katsumoto Y; Ito Y; Wakasugi E; Wakasugi T; Tomita N; Shimano T; Mori T
Biotherapy; 1993; 7(1):47-54. PubMed ID: 8068483
[TBL] [Abstract][Full Text] [Related]
26. [Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes].
Kan N; Okino T; Nakanishi M; Satou K; Mise K; Ohgaki K; Hori T; Kodama H; Tobe T
Hum Cell; 1988 Sep; 1(3):289-96. PubMed ID: 2979206
[TBL] [Abstract][Full Text] [Related]
27. [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].
Okino T; Kan N; Mise K; Nakanishi M; Satoh K; Yamasaki S; Teramura Y; Inoue K; Ohgaki K; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):613-20. PubMed ID: 2351854
[TBL] [Abstract][Full Text] [Related]
28. [Immunotherapy of gastric cancer].
Kan N; Ohgaki K; Okino T; Nakanishi M; Nio Y; Inoue K; Tobe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):755-62. PubMed ID: 3291771
[TBL] [Abstract][Full Text] [Related]
29. Adoptive immunotherapy for malignant brain tumors using human peripheral blood mononuclear cells activated by the Streptococcal preparation OK-432.
Hirotsu T; Mineta T; Ichinose M; Toda K; Fukuyama K; Tabuchi K
Neurol Med Chir (Tokyo); 2001 Aug; 41(8):387-92. PubMed ID: 11561349
[TBL] [Abstract][Full Text] [Related]
30. Changes in immunological parameters in lung cancer patients undergoing immunotherapy with streptococcal preparation OK-432.
Watanabe Y; Shimizu J; Hashizume Y; Tsunamura Y; Yamada T; Iwa T; Sakai S; Murayama T; Koshimura S; Saito M
Biotherapy; 1990; 2(3):235-45. PubMed ID: 2206775
[TBL] [Abstract][Full Text] [Related]
31. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
[TBL] [Abstract][Full Text] [Related]
32. Establishment of animal liver metastatic model for C-1300 murine neuroblastoma and immunotherapy for it using OK-432, streptococcus preparation.
Naito H; Ziegler MM; Miyakawa A; Tokunaga O; Sasaki M
J Surg Res; 1992 Jan; 52(1):79-84. PubMed ID: 1548871
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group.
Noda K; Teshima K; Tekeuti K; Hasegawa K; Inoue K; Yamashita K; Sawaragi I; Nakajima T; Takashima E; Ikeuchi M
Gynecol Oncol; 1989 Dec; 35(3):367-72. PubMed ID: 2689304
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial.
Domschke C; Ge Y; Bernhardt I; Schott S; Keim S; Juenger S; Bucur M; Mayer L; Blumenstein M; Rom J; Heil J; Sohn C; Schneeweiss A; Beckhove P; Schuetz F
Cancer Immunol Immunother; 2013 Jun; 62(6):1053-60. PubMed ID: 23595207
[TBL] [Abstract][Full Text] [Related]
35. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
[TBL] [Abstract][Full Text] [Related]
36. [Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU].
Tomita F; Kurosaka Y; Matsushita M; Akiyama T; Kiriyama M; Hitoshi ; Kosaka T; Kita I; Takashima S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2190-3. PubMed ID: 7944437
[TBL] [Abstract][Full Text] [Related]
37. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
38. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
39. Peri-operative immunotherapy with OK-432.
Yokota M; Tagawa Y; Okada D; Yasutake T; Mine Y; Ishikawa H; Miyashita K; Tomita M; Tabuchi S
Biotherapy; 1990; 2(3):207-12. PubMed ID: 2206773
[TBL] [Abstract][Full Text] [Related]
40. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients.
Stehlin JS; de Ipolyi PD; Greeff PJ; McGaff CJ; Davis BR; McNary L
Ann Surg; 1988 Jul; 208(1):23-35. PubMed ID: 2839123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
